ARCHIVES

No Cancer Letter For Two Weeks

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989